Future Care Charles Village | |
2327 N. Charles St, Baltimore, Maryland 21218 | |
(410) 889-8500 | |
Name | Future Care Charles Village |
---|---|
Location | 2327 N. Charles St, Baltimore, Maryland |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 109 |
Occupancy Rate | 75.23% |
Medicare ID (CCN) | 215324 |
Legal Business Name | Futurecare Charles Village, Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1386632800 |
Organization Name | FUTURE CARE-CHARLES VILLAGE, LLC |
Doing Business As | FUTURECARE CHARLES VILLAGE |
Address | 2327 N Charles St, Baltimore, MD 21218 |
Phone Number | 410-889-8500 |
News Archive
An EU-funded project has developed new approaches to tackling chronic inflammatory diseases. These will be used to create precise and individualized treatment options, potentially leading to faster diagnosis, more effective treatments and even cures.
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
More Americans were vaccinated against seasonal flu during the 2009-10 season (40 percent of eligible population) than during the previous flu season (33 percent of eligible population), according to a report by the Centers for Disease Control and Prevention.
My Cancer Genome (MCG), an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled a free, second-generation mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations.
› Verified 8 days ago
NPI Number | 1831553742 |
Organization Name | FUTURE CARE-CHARLES VILLAGE, LLC |
Doing Business As | FUTURECARE CHARLES VILLAGE |
Address | 2327 N Charles St, Baltimore, MD 21218 |
Phone Number | 410-889-8500 |
News Archive
An EU-funded project has developed new approaches to tackling chronic inflammatory diseases. These will be used to create precise and individualized treatment options, potentially leading to faster diagnosis, more effective treatments and even cures.
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
More Americans were vaccinated against seasonal flu during the 2009-10 season (40 percent of eligible population) than during the previous flu season (33 percent of eligible population), according to a report by the Centers for Disease Control and Prevention.
My Cancer Genome (MCG), an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled a free, second-generation mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations.
› Verified 8 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
An EU-funded project has developed new approaches to tackling chronic inflammatory diseases. These will be used to create precise and individualized treatment options, potentially leading to faster diagnosis, more effective treatments and even cures.
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
More Americans were vaccinated against seasonal flu during the 2009-10 season (40 percent of eligible population) than during the previous flu season (33 percent of eligible population), according to a report by the Centers for Disease Control and Prevention.
My Cancer Genome (MCG), an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled a free, second-generation mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations.
› Verified 8 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 17.04 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.69 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 71.88 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.97 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 1.21 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 14.8 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.2 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 92.8 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 15.84 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 79.37 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.76 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 52.88 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.96 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 12.55 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.23 | 95.98 |
Percentage of short-stay residents who made improvements in function | 66.34 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.79 | 82.93 |
News Archive
An EU-funded project has developed new approaches to tackling chronic inflammatory diseases. These will be used to create precise and individualized treatment options, potentially leading to faster diagnosis, more effective treatments and even cures.
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
More Americans were vaccinated against seasonal flu during the 2009-10 season (40 percent of eligible population) than during the previous flu season (33 percent of eligible population), according to a report by the Centers for Disease Control and Prevention.
My Cancer Genome (MCG), an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled a free, second-generation mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations.
› Verified 8 days ago
King David Nursing And Rehabilitation Center Location: 4204 Old Milford Mill Road, Baltimore, Maryland 21208 Phone: (410) 486-1500 | |
Autumn Lake Healthcare At Long Green Location: 115 East Melrose Avenue, Baltimore, Maryland 21212 Phone: (410) 435-9073 | |
Levindale Hebrew Ger Ctr & Hsp Location: 2434 W. Belvedere Avenue, Baltimore, Maryland 21215 Phone: (410) 466-8700 | |
Keswick Multi-care Center Location: 700 West 40th Street, Baltimore, Maryland 21211 Phone: (410) 235-8860 | |
St. Elizabeth Rehab. & Nsg. Ce Location: 3320 Benson Avenue, Baltimore, Maryland 21227 Phone: (667) 600-2600 | |
Autumn Lake Healthcare At Homewood Location: 6000 Bellona Avenue, Baltimore, Maryland 21212 Phone: (410) 323-4223 |